Microgestin 1.5/30 Kit
Product Images NDC 51862-872

Product Visual Gallery

This gallery contains 12 technical images submitted to the FDA as part of the official labeling for Microgestin 1.5/30 (NDC 51862-872). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Mayne Pharma Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

1 (Image 01)

Chemical structure diagram showing the molecular formulas of Norethindrone Acetate and Ethinyl Estradiol, the active ingredients in Microgestin 1.5/30. The left structure is labeled Norethindrone Acetate and the right structure is labeled Ethinyl Estradiol.*

FDA Label Image

2 (Image 02)

A data table titled "Lowest Expected and Typical Failure Rates During the First Year of Continuous Use of a Method," listing percentages of women experiencing unintended pregnancy with various contraceptive methods during the first year. Methods include no contraception, oral contraceptives (combined and progestin only), diaphragm, spermicides, vaginal sponge, implants, injections, IUDs, condoms, cervical cap, abstinence, withdrawal, and sterilization with columns for lowest expected and typical failure rates.*

FDA Label Image

3 (Image 03)

Text panel warning that cigarette smoking increases the risk of serious cardiovascular side effects from oral contraceptive use. It highlights that this risk increases with age and heavy smoking (15 or more cigarettes daily), especially in women over 35 years. It advises women using oral contraceptives to avoid smoking.*

FDA Label Image

4 (Image 04)

A bar chart titled 'Table II Circulatory Disease Mortality Rates per 100,000 Woman Years by Age, Smoking Status and Oral Contraceptive Use'. It compares mortality rates among four groups: ever-users (non-smokers), ever-users (smokers), controls (non-smokers), and controls (smokers) across different age ranges (15-24, 25-34, 35-44, and 45+). Mortality rates are shown on the vertical axis up to 250 deaths per 100,000 woman years.*

FDA Label Image

5 (Image 05)

A data table titled 'Annual Number of Birth-Related or Method-Related Deaths Associated with Control of Fertility per 100,000 Nonsterile Women by Fertility Control Method According to Age.' It presents death rates by age groups (15-19 to 40-44) for various fertility control methods, including no fertility control, oral contraceptives (smoker and non-smoker), IUD, condom, diaphragm/spermicide, and periodic abstinence, with notes specifying birth-related and method-related deaths.*

FDA Label Image

6 (Image 06)

Warning text panel stating that cigarette smoking increases the risk of serious cardiovascular side effects from oral contraceptive use, with heightened risk for women over 35 years of age and those who smoke 15 or more cigarettes per day.*

FDA Label Image

7 (Image 07)

An instructional diagram showing how to start taking Microgestin 1.5/30 tablets. It shows a hand peeling back a day-of-week label sticker on a weekly pill pack with three rows of yellow active pills. The direction to take pills is indicated from left to right each week, and instructions are provided for users to place the day label sticker according to the first day of their period if different from Sunday.*

FDA Label Image

8 (Image 08)

A text panel warning that cigarette smoking increases the risk of serious cardiovascular side effects from oral contraceptive use, especially in women over 35 years and heavy smokers (15 or more cigarettes per day). It advises women using oral contraceptives not to smoke.*

FDA Label Image

9 (Image 09)

A data table presenting the annual number of birth-related or method-related deaths per 100,000 nonsterile women by fertility control method and age group. Methods include no fertility control, oral contraceptives (smoker and non-smoker), IUD, condom, diaphragm/spermicide, and periodic abstinence, with data segmented by age ranges 15-19 through 40-44.*

FDA Label Image

10 (Image 10)

An instructional diagram for the Microgestin 1.5/30 contraceptive kit shows a hand peeling back a day label sticker with days of the week to be placed on the pill blister pack. The diagram indicates how to align the sticker depending on the start day of the menstrual cycle, with labeled yellow active pills arranged left to right for weekly dosing. Arrows show the direction to take pills from left to right each week.*

FDA Label Image

11 (Image 11)

FDA Label Image

12 (Image 12)

Microgestin 1.5/30 Kit packaging label for Norethindrone Acetate and Ethinyl Estradiol tablets, USP. The label shows the product name and strength, manufacturer Mayne Pharma, and details including each yellow tablet contains 1.5 mg norethindrone acetate and 0.03 mg ethinyl estradiol. The package contains 6 blister cards of 21 tablets each. It also includes storage instructions and a barcode.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.